Early Initiation of Continuous Renal Replacement Therapy Improves Clinical Outcomes in Patients With Acute Respiratory Distress Syndrome

被引:48
作者
Han, Fang [1 ]
Sun, Renhua [1 ]
Ni, Yin [1 ]
Hu, Xiuping [1 ]
Chen, Xv [1 ]
Jiang, Lingzhi [1 ]
Wu, Aiping [1 ]
Ma, Leilei [1 ]
Chen, Minhua [1 ]
Xv, Yunxiang [1 ]
Tu, Yuexing [1 ]
机构
[1] Zhejiang Prov Peoples Hosp, Intens Care Unit, Hangzhou 310014, Zhejiang, Peoples R China
关键词
Critically ill; ARDS; CRRT; Cytokines; TGF-beta; 1; ACUTE LUNG INJURY; GROWTH-FACTOR-BETA; PEAK CONCENTRATION HYPOTHESIS; CRITICALLY-ILL PATIENTS; ACUTE KIDNEY INJURY; TRANSFORMING GROWTH-FACTOR-BETA-1; TGF-BETA; SEPSIS; ARDS; TRANSPLANTATION;
D O I
10.1097/MAJ.0000000000000379
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: The acute respiratory distress syndrome (ARDS) is a common devastating syndrome in intensive care unit in critically ill patients. Continuous renal replacement therapy (CRRT) has been shown beneficial effects on oxygenation and survival in patients with ARDS. However, it is still controversial about the timing of initiation of CRRT. Methods: Fifty-three patients with ARDS admitted to intensive care unit in Zhejiang Provincial People's Hospital, China from 2009 to 2013 were enrolled in the study. The authors compared ventilation parameter, including PaO2/FIO2, A-a gradient, positive endexpiratory pressure, plateau pressure, dynamic compliance and hemodynamic parameters, including central venous pressure, mean arterial pressure, cardiac index, extravascular lung water index, fluid balance between early initiation (within 12 hours after ARDS onset) and late initiation of CRRT (48 hours after ARDS onset) groups. The authors further investigated transforming growth factor (TGF)-beta 1 level changes in serum and bronchoalveolar lavage fluid (BALF) by enzyme-linked immunosorbent assay during 7 days of follow-up. Results: Significant improvement of oxygenation and shorter duration of mechanical ventilation were observed in early CRRT group during 7-day follow-up. In addition, TGF-beta 1 concentrations in serum and BALF were significantly decreased in patients with early initiation of CRRT compared to those with late initiation of CRRT on day 2 and day 7. Furthermore, patients who died of ARDS had higher levels of TGF-b1 in BALF than survivors. Conclusions: Our findings showed that early initiation of CRRT is associated with favorable clinical outcomes in ARDS patients, which might be due to the reduced serum and BALF TGF-beta 1 levels through CRRT. However, large multi-center studies are needed to make further recommendations as to the optimal use of CRRT in ARDS patient populations.
引用
收藏
页码:199 / 205
页数:7
相关论文
共 45 条
[1]  
Cuza AAA, 2012, MEDICC REV, V14, P26, DOI 10.37757/MR2012V14.N3.5
[2]  
ADAMS DH, 1991, J IMMUNOL, V147, P609
[3]   Timing of renal replacement therapy and clinical outcomes in critically ill patients with severe acute kidney injury [J].
Bagshaw, Sean M. ;
Uchino, Shigehiko ;
Bellomo, Rinaldo ;
Morimatsu, Hiroshi ;
Morgera, Stanislao ;
Schetz, Miet ;
Tan, Ian ;
Bouman, Catherine ;
Macedo, Ettiene ;
Gibney, Noel ;
Tolwani, Ashita ;
Oudemans-van Straaten, Heleen M. ;
Ronco, Claudio ;
Kellum, John A. .
JOURNAL OF CRITICAL CARE, 2009, 24 (01) :129-140
[4]   The role of transforming growth factor β in lung development and disease [J].
Bartram, U ;
Speer, CP .
CHEST, 2004, 125 (02) :754-765
[5]   TGF-β1 inhibits surfactant component expression and epithelial cell maturation in cultured human fetal lung [J].
Beers, MF ;
Solarin, KO ;
Guttentag, SH ;
Rosenbloom, J ;
Kormilli, A ;
Gonzales, LW ;
Ballard, PL .
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 1998, 275 (05) :L950-L960
[6]   Extracorporeal blood treatment (EBT) methods in SIRS/sepsis [J].
Bellomo, R ;
Honoré, P ;
Matson, J ;
Ronco, C ;
Winchester, J .
INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 2005, 28 (05) :450-458
[7]   THE AMERICAN-EUROPEAN CONSENSUS CONFERENCE ON ARDS - DEFINITIONS, MECHANISMS, RELEVANT OUTCOMES, AND CLINICAL-TRIAL COORDINATION [J].
BERNARD, GR ;
ARTIGAS, A ;
BRIGHAM, KL ;
CARLET, J ;
FALKE, K ;
HUDSON, L ;
LAMY, M ;
LEGALL, JR ;
MORRIS, A ;
SPRAGG, R ;
COCHIN, B ;
LANKEN, PN ;
LEEPER, KV ;
MARINI, J ;
MURRAY, JF ;
OPPENHEIMER, L ;
PESENTI, A ;
REID, L ;
RINALDO, J ;
VILLAR, J ;
VANASBECK, BS ;
DHAINAUT, JF ;
MANCEBO, J ;
MATTHAY, M ;
MEYRICK, B ;
PAYEN, D ;
PERRET, C ;
FOWLER, AA ;
SCHALLER, MD ;
HUDSON, LD ;
HYERS, T ;
KNAUS, W ;
MATTHAY, R ;
PINSKY, M ;
BONE, RC ;
BOSKEN, C ;
JOHANSON, WG ;
LEWANDOWSKI, K ;
REPINE, J ;
RODRIGUEZROISIN, R ;
ROUSSOS, C ;
ANTONELLI, MA ;
BELOUCIF, S ;
BIHARI, D ;
BURCHARDI, H ;
LEMAIRE, F ;
MONTRAVERS, P ;
PETTY, TL ;
ROBOTHAM, J ;
ZAPOL, W .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1994, 149 (03) :818-824
[8]   Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. [J].
Brower, RG ;
Matthay, MA ;
Morris, A ;
Schoenfeld, D ;
Thompson, BT ;
Wheeler, A ;
Wiedemann, HP ;
Arroliga, AC ;
Fisher, CJ ;
Komara, JJ ;
Perez-Trepichio, P ;
Parsons, PE ;
Wolkin, R ;
Welsh, C ;
Fulkerson, WJ ;
MacIntyre, N ;
Mallatratt, L ;
Sebastian, M ;
McConnell, R ;
Wilcox, C ;
Govert, J ;
Thompson, D ;
Clemmer, T ;
Davis, R ;
Orme, J ;
Weaver, L ;
Grissom, C ;
Eskelson, M ;
Young, M ;
Gooder, V ;
McBride, K ;
Lawton, C ;
d'Hulst, J ;
Peerless, JR ;
Smith, C ;
Brownlee, J ;
Pluss, W ;
Kallet, R ;
Luce, JM ;
Gottlieb, J ;
Elmer, M ;
Girod, A ;
Park, P ;
Daniel, B ;
Gropper, M ;
Abraham, E ;
Piedalue, F ;
Glodowski, J ;
Lockrem, J ;
McIntyre, R .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (18) :1301-1308
[9]   Active transforming growth factor-β1 activates the procollagen I promoter in patients with acute lung injury [J].
Budinger, GRS ;
Chandel, NS ;
Donnelly, HK ;
Eisenbart, J ;
Oberoi, M ;
Jain, M .
INTENSIVE CARE MEDICINE, 2005, 31 (01) :121-128
[10]   Can modification of renal replacement therapy improve the outcome of patients with systemic inflammatory response syndrome? [J].
Davenport, A .
BLOOD PURIFICATION, 2006, 24 (03) :317-318